These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2422484)
1. Hydralazine and its metabolites: in vitro and in vivo activity in the rat. Criscione L; Eichenberger K; Hedwall PR; Schmid K J Cardiovasc Pharmacol; 1986; 8(2):420-7. PubMed ID: 2422484 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of formation and excretion of some metabolites of hydralazine and their hypotensive effect in rats. Ogiso T; Iwaki M; Ohtsuki N J Pharmacol Exp Ther; 1985 May; 233(2):485-90. PubMed ID: 3999031 [TBL] [Abstract][Full Text] [Related]
3. Hypotensive effect of the hydralazine--acetone hydrazone in conscious rabbits: evidence for its back-conversion to hydralazine in vivo. Talseth T; McNay JL; Haegele KD J Cardiovasc Pharmacol; 1982; 4(3):370-4. PubMed ID: 6177931 [TBL] [Abstract][Full Text] [Related]
5. Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normotensive rats. Orallo F Br J Pharmacol; 1997 Aug; 121(8):1627-36. PubMed ID: 9283696 [TBL] [Abstract][Full Text] [Related]
6. Study of in vitro effects of hydralazine metabolites--comparative evaluation of products of hydroxylation, hydrolysis and conjugation. McLean AJ; du Souich P; Barron K; Carrier O; Haegele KD; McNay JL Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):19-25. PubMed ID: 736689 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the in vitro effects of hydralazine and hydralazine acetonide on arterial smooth muscle. Barron K; Carrier O; Haegele KD; McLean AJ; McNay JL; Du Souich P Br J Pharmacol; 1977 Nov; 61(3):345-9. PubMed ID: 588802 [TBL] [Abstract][Full Text] [Related]
8. Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats. Greeberg S J Pharmacol Exp Ther; 1980 Nov; 215(2):279-86. PubMed ID: 7441494 [TBL] [Abstract][Full Text] [Related]
9. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK; Dubinion JH; Mi Z Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [TBL] [Abstract][Full Text] [Related]
10. Copper induces vasorelaxation and antagonizes noradrenaline-induced vasoconstriction in rat mesenteric artery. Wang YC; Hu CW; Liu MY; Jiang HC; Huo R; Dong DL Cell Physiol Biochem; 2013; 32(5):1247-54. PubMed ID: 24247276 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats. Shin HS; Seo HW; Oh JH; Lee BH Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113 [TBL] [Abstract][Full Text] [Related]
12. Effect of urethane on hydralazine-induced tachycardia in rats. Orallo F; Fontenla JA; Loza MI; Campos M; Calleja JM Gen Pharmacol; 1992 Nov; 23(6):1143-7. PubMed ID: 1487125 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat. Webb RL; McNeal RB; Barclay BW; Yasay GD J Pharmacol Exp Ther; 1990 Sep; 254(3):1090-9. PubMed ID: 2203898 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of hydralazine and nifedipine on contractions and 45Ca influx of rat aorta. Orallo F; Gil-Longo J; Bardán B; Calleja JM J Pharm Pharmacol; 1991 May; 43(5):356-9. PubMed ID: 1680180 [TBL] [Abstract][Full Text] [Related]
15. The effects of perfusion rate and NG-nitro-L-arginine methyl ester on cirazoline- and KCl-induced responses in the perfused mesenteric arterial bed of rats. Adeagbo AS; Tabrizchi R; Triggle CR Br J Pharmacol; 1994 Jan; 111(1):13-20. PubMed ID: 7912152 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, formulation, and clinical pharmacological evaluation of hydralazine pyruvic acid hydrazone in two healthy volunteers. Reece PA; Stafford I; Prager RH; Walker GJ; Zacest R J Pharm Sci; 1985 Feb; 74(2):193-6. PubMed ID: 3989691 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by hydralazine of the conversion of dopamine to noradrenaline in rat atria in vitro and in vivo. Songkittiguna P; Majewski H; Rand MJ Clin Exp Pharmacol Physiol; 1980; 7(5):509-14. PubMed ID: 7449192 [TBL] [Abstract][Full Text] [Related]
19. Hydralazine inhibits vascular reactivity by a mechanism independent of vascular prostaglandin biosynthesis: role of thromboxane synthetase in blocking hydralazine actions. Ally AI; Horrobin DF Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):39-63. PubMed ID: 3462852 [TBL] [Abstract][Full Text] [Related]
20. Studies on the in vivo metabolism of hydralazine in the rat. Streeter AJ; Timbrell JA Drug Metab Dispos; 1983; 11(3):184-9. PubMed ID: 6135573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]